MYC and liver cancer: For example, amplification of oncogenes (EFGR, ERBB2, and MYC) occurs via BFB in up to ~70% of diverse tumor types (including breast, colorectal, lung, and liver cancers) (Marotta et al., 2017; Venkataram et al., 2016).